<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Dementia Imaging</title>
<style>
    body {
        margin: 0;
        font-family: Arial, sans-serif;
        background-color: #f9f9f9;
        color: #222;
    }

    .slide {
        display: none;
        box-sizing: border-box;
        height: 100vh;
        width: 100%;
        padding: 4rem 10%;
        font-size: 1.6rem;
        line-height: 1.4;
        overflow-y: auto;
    }

    h1, h2, h3 {
        text-align: center;
        margin-top: 0;
    }

    p, ul, ol {
        text-align: left;
        margin-left: auto;
        margin-right: auto;
        max-width: 1000px;
    }

    ul, ol {
        padding-left: 2rem;
    }

    li {
        margin-bottom: 0.6rem;
    }

    @media (max-width: 768px) {
        .slide {
            padding: 2rem 1.5rem;
            font-size: 1.3rem;
        }
    }

    img {
        display: block;
        margin: 2rem auto;
        max-width: 80%;
        height: auto;
        max-height: 100%;
    }

    small {
        font-size: 10px
    }

</style>
</head>
<body>

<div class="slide" style="display: block;">
    <h1>Imaging of Dementia</h1>
    <h2>Patrick J Rock, M.D.</h2>
</div>

<div class="slide">
    <h1>Goals</h1>
    <ul>
        <li>Review common etiologies and imaging features</li>
        <li>Recognize key anatomy relevant to dementia</li>
        <li>Interpret major visual rating scales</li>
        <li>Correlate PET and MR findings with pathology</li>
    </ul>
</div>

<div class="slide">
    <h1>Definition</h1>
    <p>Dementia is a clinical syndrome charactarized by progressive decline in cognitive function severe enough to interfere with daily lifes.</p>
</div>

<div class="slide">
        <img src="https://www.economist.com/media-assets/image/20220115_WOF376.jpg">
</div>

<div class="slide">
    <h1>What is the role of imaging in dementia?</h1>
    <ol>
        <li>Exclude structural and secondary causes</li>
        <li>Evaluate cerebral volume loss</li>
        <li>Assess degree of vascular disase</li>
        <li>Identify microhemorrhage</li>
    </ol>
</div>

<div class="slide">
    <h1>MR Protocol for Dementia</h1>
    <ul>
        <li>T1 — atrophy patterns, MTA/GCA scoring</li>
        <li>T2/FLAIR — white matter disease (Fazekas)</li>
        <li>DWI — restricted diffusion (CJD, infarcts)</li>
        <li>SWI — microhemorrhages, amyloid angiopathy</li>
        <li>Coronal through hippocampus</li>
        <li>3D T1 for volumetric analysis</li>
    </ul>
</div>

<div class="slide">
    <img src="https://pubs.rsna.org/cms/10.1148/radiol.230173/asset/images/large/radiol.230173.va.jpeg">
</div>

<div class="slide">
    <h1>Anatomic structures</h1>
    <ul>
        <li>Choroid fissure</li>
	    <li>Hippocampus</li>
        <li>Collateral sulcus</li>
 	    <li>Parahippocampal gyrus</li>
        <hr>
	    <li>Precuneus</li>
	    <li>Cingulate sulcus</li>
		<li>Marginal branch</li>
	    <li>Parieto-occipital sulcus</li>
    </ul>
</div>

<div class="slide">
    <img width="60%" src="https://radiologyassistant.nl/assets/dementia-role-of-mri/a50979771d06cf_FIG-hippoc-5.jpg">
    <small>Image courtesy of Radiology Assistant</small>
    <hr>
    <img src="https://pubs.rsna.org/cms/10.1148/rg.2020190070/asset/images/medium/rg.2020190070.fig2b.gif">
</div>

<div class="slide">
    <img src="https://prod-images-static.radiopaedia.org/images/25104404/5429b6963f3a6d560f3b50a9df3781_big_gallery.jpeg">
    <small>Gaillard F, Neuroanatomy: medial cortex (diagrams). Case study, Radiopaedia.org (Accessed on 08 Oct 2025) https://doi.org/10.53347/rID-47208</small>
</div>

<div class="slide">
    <h1>Common Etiologies</h1>
    <ul>
        <li>Alzheimer disease</li>
        <li>Vascular dementia</li>
        <li>Frontotemporal lobar degeneration</li>
        <li>Lewy body dementia</li>
        <li>Parkinson’s-related</li>
        <li>CJD and prion diseases</li>
    </ul>
</div>

<div class="slide">
    <h1>Alzheimer's disease</h1>
    <img src="https://prod-images-static.radiopaedia.org/images/3060519/downloaded_image20240531-964-3xflgv_big_gallery.jpeg" style="display: inline" width="30%">
    <img src="https://prod-images-static.radiopaedia.org/images/3060579/downloaded_image20240531-982-pn723l_big_gallery.jpeg" style="display: inline" width="30%">
    <img src="https://prod-images-static.radiopaedia.org/images/3060577/downloaded_image20240531-951-uzwhpg_big_gallery.jpeg" style="display: inline" width="30%">
    <ul>
        <li>Widening of the temporal horns</li>
        <li>Hippocampal atrophy</li>
        <li>Parietal lobe atrophy not as impressive in this case</li>
    </ul>
</div>

<div class="slide">
    <img src="https://pubs.rsna.org/cms/10.1148/radiol.230173/asset/images/medium/radiol.230173.fig1.gif" title="MRI scans in an 83-year-old male patient with typical Alzheimer disease (AD). Coronal T1-weighted image (A) shows predominant atrophy of the hippocampus (arrows). This is associated with hypoperfusion of the posterior cingulate cortex (arrow), known as absent light bulb sign, on the arterial spin labeling image (B). In a healthy individual, the perfusion at rest of the posterior cingulate cortex should be as least as high as the remaining gray matter resulting in a “light bulb” appearance. (C, D) MRI scans in a 65-year-old male patient show predominant parietal atrophy (arrows) suggestive of an atypical parietal variant of AD. The parietal variant of AD often affects younger patients and can be asymmetric. Corresponding arterial spin labeling image (D) shows associated hypoperfusion, which is likely overestimated by the atrophy/partial volume effect.">
    <small>Neuroimaging in Dementia: More than Typical Alzheimer Disease. Sven Haller, Hans Rolf Jäger, Meike W. Vernooij, and Frederik Barkhof. Radiology 2023 308:3<small>
</div>

<div class="slide">
    <h1>Visual Rating Scales</h1>
    <ul>
        <li><strong>MTA (Medial Temporal Atrophy):</strong> hippocampal volume loss</li>
        <li><strong>GCA (Global Cortical Atrophy):</strong> generalized cortical thinning</li>
        <li><strong>Fazekas:</strong> periventricular and deep white matter changes</li>
        <li><strong>PSCI:</strong> post-stroke cognitive impairment</li>
    </ul>
</div>

<div class="slide">
    <h1>Medial temporal lobe atrophy score</h1>
    <img src="https://radiologyassistant.nl/img/containers/main/dementia-role-of-mri/a517d064d61cd0__MTA-score.jpg/3a5f9d21b207f4c01db78d98084aa155.jpg">
    <ul>    
        <li>0: no CSF is visible around the hippocampus</li>
        <li>1: choroid fissure is slightly widened</li>
        <li>2: moderate widening of the choroid fissure, mild enlargement of the temporal horn and mild loss of hippocampal height</li>
        <li>3: marked widening of the choroid fissure, moderate enlargement of the temporal horn, and moderate loss of hippocampal height</li>
        <li>4: marked widening of the choroid fissure, marked enlargement of the temporal horn, and the hippocampus is markedly atrophied and internal structure is lost</li>
    </ul>
    <small>Case courtesy of Radiology Assistant</small>
</div>

<div class="slide">
    <h1>Koedam score for parietal lobe atrophy</h1>
    <img  src="https://epos.myesr.org/posterimage/esr/ecr2022/160479/media/917365" style="display: inline" width="50%">
    <img  src="https://radiologyassistant.nl/assets/tab-4-koedam-b-1646648074.png" style="display: inline">
</div>

<div class="slide">
    <h1>Global cortical atrophy <i>scale</i></h1>
    <img src="https://staging.radiologyassistant.nl/img/containers/assets/gca-score.jpg/8aabb7803fc2fc78c80a1494f8568d56/gca-score.jpg">
    <ul>
        <li>0: normal volume / no ventricular enlargement</li>
        <li>1: opening of sulci / mild ventricular enlargement</li>
        <li>2: volume loss of gyri / moderate ventricular enlargement</li>
        <li>3: 'knife blade' atrophy / severe ventricular enlargement</li>
    </ul>
</div>



<div class="slide">
    <h1>Other Types of Dementia That Mimic AD</h1>
    <img src="https://pubs.rsna.org/cms/10.1148/radiol.230173/asset/images/large/radiol.230173.fig5.jpeg">
    <p style="font-size: 0.8em">Pie chart shows the classic distribution of dementia types in a memory clinic setting, where most cases (60%) are Alzheimer disease (AD). Although AD is attributed to the majority of cases, 40% are not AD. Reprinted, with permission, from reference 32. (B) Pie chart shows, according to recent studies, that within the AD group, less than half of cases are isolated AD, while more than half of cases are various combinations of mixed pathologies that include AD. HS = hippocampal sclerosis, LBD = Lewy body dementia, VaD = vascular dementia.</p>
    <small>From Neuroimaging in Dementia: More than Typical Alzheimer Disease<small>
</div>

<div class="slide">
    <h1>Cerebrovascular Disease Subtypes</h1>
    <ul>
        <li>White matter hyperintensities</li>
        <li>Microbleeds</li>
        <li>Enlarged perivascular spaces</li>
        <li>État criblé = enlarged perivascular spaces at the level of the basal ganglia</li>
        <li>Strategic lacunes</li>
        <li>Cortical microinfarcts</li>
        <li>Hippocampal microinfarcts</li>
    </ul>
</div>

<div class="slide">
    <h1>Cerebrovascular Disease Subtypes</h1>
    <hr>
    <h2>White matter hyperintensities</h2>
    <ul>
        <li>Seen in 90% of adults over 40</li>
        <li>Increase with age</li>
        <li>Generally correlates with risk of strokes and cognitive decline</li>
    </ul>
    <img src="https://prod-images-static.radiopaedia.org/images/4975522/4beae914c5d7171ad890b8baea0e02222219b4432657ff886d807bcc747412cf_big_gallery.jpeg">
    <small>Gaillard F, Vascular dementia. Case study, Radiopaedia.org (Accessed on 07 Oct 2025) https://doi.org/10.53347/rID-25641</small>
</div>

<div class="slide">
    <h1>Fazekas Scale</h1>
    <img src="https://prod-images-static.radiopaedia.org/images/12735148/e69c30bde439e5a216128284f7a681_big_gallery.jpeg"</img>
<ul>
  <li><strong>Grade 0:</strong> No white matter lesions.</li>
  <li><strong>Grade 1:</strong> Punctate foci of white matter hyperintensity.</li>
  <li><strong>Grade 2:</strong> Beginning confluence of lesions.</li>
  <li><strong>Grade 3:</strong> Large confluent white matter changes.</li>
</ul>

</div>

<div class="slide">
    <h1>Cerebrovascular Disease Subtypes</h1>
    <hr>
    <h2>Microbleeds</h2>
    <ul>
        <li>Also associated with aging and cognitive decline; </li>
        <li>Deep → hypertension; </li>
        <li>Lobar → cerebral amyloid angiopathy; </li>
        <li>While CAA is associated with AD, itis only seen in ~20-30% of cases; </li>
        <li>Absence of CAA does not rule out AD; </li>
    </ul>
    <img src="https://prod-images-static.radiopaedia.org/images/9487/d6b76e5a8b0d7f3a096f821cd75596_big_gallery.jpeg">
    <small>Gaillard F, Chronic hypertensive encephalopathy. Case study, Radiopaedia.org (Accessed on 07 Oct 2025) https://doi.org/10.53347/rID-4564</small>
</div>

<div class="slide">
    <h1>Cerebrovascular Disease Subtypes</h1>
    <hr>
    <h2>Enlarged perivascular spaces</h2>
    <img src="https://prod-images-static.radiopaedia.org/images/1066/82467510bceaf97ae86d3d2b8001caa1cfff63377f08f6727b2e1afa98899d9b_big_gallery.jpeg">
    <ul>
        <li>Aka dilated Virchow-Robin spaces</li>
        <li>Recently emerged as a potential marker of cerebrovascular disease</li>
        <li>Possibly due to hypertension, altered CSF dynamics, inflammation</li>
        <li>Also associated with CAA</li>
    </ul>
</div>

<div class="slide">
    <h1>Cerebrovascular Disease Subtypes</h1>
    <hr>
    <h2>État Criblé</h2>
    <img src="https://prod-images-static.radiopaedia.org/images/824/d221ad48bfcc76a3b98883fba80855_big_gallery.jpeg">
    <ul>
        <li>Special type of enlarged perivascular spaces at the level of the basal ganglia</li>
        <li>More direct and important cerebrovascular disease marker and almost invariably associated with confluent white matter hyperintensities.</li>
    <small>Gaillard F, État criblé. Case study, Radiopaedia.org (Accessed on 08 Oct 2025) https://doi.org/10.53347/rID-35970</small>
</div>

<div class="slide">
    <h1>Cerebrovascular Disease Subtypes</h1>
    <hr>
    <h2>Strategic lacunes</h2>
    <br>
    <img src="https://prod-images-static.radiopaedia.org/images/156921/9a712ec1747f433060dcc89cea52e3.jpg">
    <p>Lacunar infarcts in the basal ganglia and thalami</p>
</div>

<div class="slide">
    <h1>Cerebrovascular Disease Subtypes</h1>
    <hr>
    <h2>Cortical microinfarcts</h2>
    <img src="https://www.ahajournals.org/cms/10.1161/STROKEAHA.118.020810/asset/0ee13097-d0d0-41d3-8f5b-5801e3ff3c56/assets/graphic/1899fig02.jpg">
    <ul>
<li>Recently acknowledge marker of cerebrovascular disease</li>
<li>Often incidentally detected on diffusion              </li>
<li>Difficult to detect otherwise                         </li>
<li>7T is great at detecting these                        </li>
<li>3T not so much                                        </li>
</ul>
</div>


<div class="slide">
    <h1>Frontotemporal lobar degeneration</h1>
    <img src="https://radiologyassistant.nl/assets/dementia-role-of-mri/a5097977227ad9_ftld-2.jpg">
    <img src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2023/02/FTD_SP16x9.jpg">
    <img src="https://radiologyassistant.nl/assets/dementia-role-of-mri/a5097977227ad9_ftld-2.jpg">
</div>

<div class="slide">
    <h1>Creutzfeldt–Jakob Disease</h1>
    <ul>
        <li>Rapidly progressive dementia</li>
        <li>Restricted diffusion in cortex and basal ganglia</li>
        <li>Caused by prion protein misfolding</li>
    </ul>
    <img src="https://upload.wikimedia.org/wikipedia/commons/b/bb/Practneurol-2016-001571f02.jpg">
</div>

<div class="slide">
    <h1>CJD and prion diseases</h1>
    <img src="https://radiologyassistant.nl/assets/dementia-role-of-mri/a5097977229bde_CJacob1.jpg">
    <ul>
  <li><strong>Diffusion-weighted imaging (DWI) cortical ribboning:</strong> patchy, asymmetric cortical hyperintensity with corresponding restricted diffusion (most sensitive MRI finding).</li>
  <li><strong>Basal ganglia diffusion abnormality:</strong> restricted diffusion and high signal on DWI/FLAIR in the caudate nuclei and putamina (often bilateral).</li>
  <li><strong>Thalamic signs:</strong> pulvinar hyperintensity ("pulvinar sign") or medial thalamic involvement; a medial-dorsal/pulvinar pattern is classically described in variant CJD.</li>
  <li><strong>FLAIR/T2 cortical and deep grey hyperintensity:</strong> cortical or deep nuclei hyperintensity on FLAIR/T2 that often overlaps with DWI changes (but DWI is usually more conspicuous).</li>
  <li><strong>Rapidly progressive distribution:</strong> imaging abnormalities typically progress rapidly over days–weeks, correlating with clinical decline.</li>
</ul>
</div>

<div class="slide">
    <h1>Dementia with Lewy Bodies</h1>
    <img src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Falzrt274/MediaObjects/13195_2014_Article_222_Fig6_HTML.jpg?as=webp" title="Examples of imaging abnormalities in dementia with Lewy bodies. (A) Dopamine transporter imaging. Both the control and Alzheimer’s disease (AD) subjects display normal dopamine transporter levels in the striatum. The dementia with Lewy bodies (DLB) subject displays reduced uptake in the putamen bilaterally, reflecting nigrostriatal degeneration. (B) Cerebral blood flow imaging. The AD subject shows decreased perfusion compared with control, particularly in the left temporal lobe. The DLB subject also exhibits perfusion deficits, but these are largely confined to posterior regions including the occipital lobes. FP-CIT, N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane; HMPAO, exametazime; SPECT, single photon emission computed tomography.
">
    <p>I-123 Ioflupane SPECT → DLB and PD will demonstrate decreased uptake in the putamen</p>
    <small>Donaghy, P.C., McKeith, I.G. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alz Res Therapy 6, 46 (2014). https://doi.org/10.1186/alzrt274</small>
</div>

<!--
<div class="slide">
    <h1>Proteinopathies</h1>
    <ul>
        <li><strong>Amyloid beta:</strong> Alzheimer disease</li>
        <li><strong>Tau:</strong> AD, PSP, CBD, FTD</li>
        <li><strong>TDP-43:</strong> FTD, ALS</li>
        <li><strong>FUS/FET:</strong> rare FTD variants</li>
        <li><strong>Prions:</strong> CJD</li>
        <li><strong>Alpha-synuclein:</strong> Parkinson’s, Lewy body</li>
    </ul>
</div>
-->


<!-- TREATABLE -->

<div class="slide">
    <h1>Treatable Causes</h1>
    <ul>
        <li>Normal pressure hydrocephalus</li>
        <li>Subdural hematoma</li>
        <li>Mass lesion or tumor</li>
        <li>Vitamin deficiency, infection, metabolic causes</li>
    </ul>
</div>

<div class="slide">
    <h1>Normal pressure hydrocephalus (NPH)</h1>
    <img src="https://prod-images-static.radiopaedia.org/images/241474/6bbbdf072be0414b6e2f159239a037.jpg">
<ul>
  <li><strong>Ventriculomegaly:</strong> enlarged ventricles out of proportion to cortical atrophy.</li>
  <li><strong>Gait disturbance:</strong> magnetic or shuffling gait.</li>
  <li><strong>Urinary incontinence:</strong> often urgency or frequency progressing to incontinence.</li>
  <li><strong>Cognitive impairment:</strong> slow thinking, apathy, or dementia.</li>
  <li><strong>“Wet, wobbly, and wacky” triad:</strong> gait, incontinence, and cognitive changes.</li>
</ul>
</div>

<div class="slide">
    <h1>Subdural hematoma</li>
    <img src="https://ars.els-cdn.com/content/image/1-s2.0-B9780444534859000222-f22-11-9780444534859.jpg">
</div>

<div class="slide">
    <h1>Tumor</li>
    <img src="https://pubs.rsna.org/cms/10.1148/rg.2020190070/asset/images/medium/rg.2020190070.fig1a.gif">
    <img src="https://pubs.rsna.org/cms/10.1148/rg.2020190070/asset/images/medium/rg.2020190070.fig1b.gif">
</div>


<!-- PET and lecanemab -->

<div class="slide">
    <h1>PET and SPECT Imaging</h1>
    <ul>
        <li><strong>FDG-PET:</strong> hypometabolism in temporoparietal regions (AD)</li>
        <li><strong>Amyvid:</strong> amyloid PET tracer (florbetapir)</li>
        <li><strong>123I-Ioflupane SPECT (DaTscan):</strong> reduced uptake in Lewy/Parkinsonian dementias</li>
    </ul>
</div>

<div class="slide">
    <img src="https://pubs.rsna.org/cms/10.1148/radiol.230173/asset/images/medium/radiol.230173.fig2.gif">
</div>

<div class="slide">
    <h1>Monoclonal antibodies that target amyloid-beta</h1>
    <img src="https://mylocalinfusion.com/wp-content/uploads/2024/10/Leqembi-vs-Aducanumab.jpg">
    <img src="https://ichef.bbci.co.uk/news/480/cpsprodpb/B659/production/_127818664_alzheimers_drug_v04_640-nc.png.webp">
</div>

<div class="slide">
    <h1>Data</h1>
    <img src="https://mma.prnewswire.com/media/1958306/EISAI_PRESENTS_FULL_RESULTS_OF_LECANEMAB.jpg?p=facebook">
</div>

<div class="slide">
    <h1><a href="https://youtu.be/-ZptbM-ntUo?si=tCnn8uPmi2LyGi2m" target="_blank">NEJM summary</a></h1>
</div>

<div class="slide">
    <h1><b>A<b/>myloid <b>R</b>elated <b>I</b>maging <b>A</b>bnormalities</h1>
    <p><b>ARIA</b> refers to MRI signal changes occurring in patients receiving amyloid-modifying therapeutic agents.</p>
    <img src="https://pubs.rsna.org/cms/10.1148/rg.230009/asset/images/medium/rg.230009.va.gif">
</div>

<div class="slide">
    <h1>ARIA-E</h1>
    <p>ARIA-E refers to increased signal on T2/FLAIR sequences in in patients receiving amyloid-modifying therapeutic agents.</p>
<img src="https://upload.wikimedia.org/wikipedia/en/f/f1/Amyloid_related_imaging_abnormalities.jpg"</img>
</div>

<div class="slide">
<h1>ARIA-H</h1>
<p>ARIA-H refers to new signal abnormalities on heme-sensitive sequences in patients receiving amyloid-modifying therapeutic agents.</p>
<img src="https://www.ajnr.org/content/ajnr/early/2022/08/25/ajnr.A7586/F7.large.jpg">
</div>



<!-- Cases -------------------------->

<div class="slide">
<h1>Case 1</h1>
<img src="images/amyvid_positive.png">
<details>
    <summary>What kind of study is this? What is the diagnosis?</summary>
    <p>Positive Florbetapir F 18 scan: decreased gray-white contrast with increased cortical radioactivity that is comparable to the
    radioactivity in the adjacent white matter.</p>
</details>
</div>

<div class="slide">
<h1>Case 2</h1>
<img src="images/amyvid_negative.png"> 
<details>
    <summary>What kind of study is this? What is the diagnosis?</summary>
    <p>Negative Florbetapir F 18 scan: normal preserved gray-white contrast with the cortical radioactivity less than the adjacent white matter. 
       The FDA label for this agent is a great resource and was the source of these cases: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202008s000lbl.pdf" target="_blank">Amyvid label</a></p>
</details>
</div>

<div class="slide">
<h1>Semantic pedantry</h1>
<details>
    <summary>What is the mesial temporal lobe?</summary>
    <p>The hippocampus and parahippocampal formation (amygdyla, parahippocampal gyrus, entorhinal cortex).</p>
</details>
</div>

<div class="slide">
<h1>Case 3</h1>
<img src="https://prod-images-static.radiopaedia.org/images/25104409/7139d66679002efb79420b3c73a883_big_gallery.jpeg" max-height:"70%">
<details>
    <summary>What is this called?</summary>
    <p>The precuneus. Cuneus is Latin for “wedge”. The precuneus comes before the wedge.</p>
</details>
</div>

<div class="slide">
<h1>Case 4</h1>
<img src="https://prod-images-static.radiopaedia.org/images/25104713/4a00fa23a8bb2a4aa8e81730c72dde_big_gallery.jpeg">
<details>
    <summary>What is this called?</summary>
    <p>The cuneus.</p>
</details>
</div>

<div class="slide">
<h1>Case 5</h1>
<img src="https://prod-images-static.radiopaedia.org/images/25104649/37c7b32a715ad55b4c90b7d3f4349e_big_gallery.jpeg">
<details>
    <summary>What is this called?</summary>
    <p><i>The Lingual Gyrus</i>. It might have been called the post cuneus, alas.</p>
</details>
</div>

<div class="slide">
<h1><a href="https://www.ajnr.org/content/quiz/01312022qz" target="_blank">AJNR Classic Case</a></h1>
</div>

<div class="slide">
<h1><a href="https://www.ajnr.org/content/quiz/08112014qz" target="_blank">Another AJNR Classic Case</a></h1>
</div>

<div class="slide">
<h1><a href="https://www.ajnr.org/content/quiz/01122015qz" target="_blank">Third AJNR Classic Case</a></h1>
</div>

<div class="slide">
    <img src="https://radiologyassistant.nl/assets/dementia-role-of-mri/a509797720c6a7_AD1.jpg">
    <details>
        <summary> What is the diagnosis?</summary>
        <p>End stage Alzheimer's. Severe nonspecific cortical atrophy</p>
</div>


<div class="slide">
<h1>References</h1>
<ol>
    <li>World Health Organization. (n.d.). <i>Dementia.</i> World Health Organization. https://www.who.int/news-room/fact-sheets/detail/dementia </li>
    <li>Neuroimaging in Dementia: More than Typical Alzheimer Disease. Sven Haller, Hans Rolf Jäger, Meike W. Vernooij, and Frederik Barkhof. Radiology 2023 308:3</li> 
    <li>Dementia - Role of MRI. Frederik Barkhof, Marieke Hazewinkel, Maja Binnewijzend and Robin Smithuis. Alzheimer Centre and Image Analysis Centre, Vrije Universiteit Medical Center, Amsterdam and the Alrijne Hospital, Leiderdorp, The Netherlands</li>
    <li>Multimodality Imaging of Dementia: Clinical Importance and Role of Integrated Anatomic and Molecular Imaging. Kunal P. Patel, David T. Wymer, Vinay K. Bhatia, Ranjan Duara, and Chetan D. Rajadhyaksha. RadioGraphics 2020 40:1, 200-222</li>
</ol>
Image references are given in source code if not present in slide.
</div>

<script>
let currentSlide = 0;
const slides = document.querySelectorAll('.slide');

function showSlide(n) {
    slides[currentSlide].style.display = 'none';
    currentSlide = (n + slides.length) % slides.length;
    slides[currentSlide].style.display = 'block';
}

function nextSlide() {
    showSlide(currentSlide + 1);
}

function previousSlide() {
    showSlide(currentSlide - 1);
}

document.addEventListener('keydown', function(event) {
    if (event.key === 'ArrowRight') nextSlide();
    else if (event.key === 'ArrowLeft') previousSlide();
});

//    document.addEventListener('wheel', function(event) {
//        if (event.deltaY > 0) nextSlide();
//        else previousSlide();
//    });

    let touchStartX = 0;
    let touchEndX = 0;

    document.addEventListener('touchstart', e => touchStartX = e.touches[0].clientX);
    document.addEventListener('touchend', e => {
        touchEndX = e.changedTouches[0].clientX;
        if (touchEndX < touchStartX) nextSlide();
        else if (touchEndX > touchStartX) previousSlide();
    });
</script>

</body>
</html>

